P
Parkway Cardiology Associates | Parkway Cardiology Associates
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
Evolocumab
EVOLocumab
Empagliflozin
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
2 of 6 total trials
This study will assess the effect of lowering low-density lipoprotein cholesterol (LDL-C) with evolocumab on major cardiovascular events in adults wi...
Active, not recruiting
Coronary Heart Disease (CHD)
Drug: Evolocumab
Drug: Placebo
The primary objective of this study is to evaluate the effectiveness of early treatment with evolocumab plus routine lipid management vs routine lipi...
Active, not recruiting
Stroke
Myocardial Infarction
Drug: Evolocumab
Drug: Routine Lipid Management
Trial sponsors
R
U
Clinical trials
Research sites
Resources
Legal
© Copyright 2024 Veeva Systems